Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
TRAFFIX logo

A new study called TrAFFix (Trial of Acute Femoral Fracture Fixation) has just opened at  the John Radcliffe Hospital in Oxford. TrAFFix will compare two different methods of fixing breaks of the thigh bone (femur), and will be rolled out across 6 hospitals in England over the next few months.

Participants aged 50 or over, who have a break in the lower part of their thigh bone (femur), may be eligible to take part. The study will help the planning of a future large trial by measuring recruitment, the completion rate of questionnaires, and assessing participant and staff impressions of the research. The future trial will compare differences in quality of life outcome when patients receive one of two common types of fixation.

TrAFFix is funded by the NIHR Health Technology Assessment Programme (Ref: 15/59/22).

Similar stories

Breakthrough in treatment for Dupuytren’s disease

Injection of the anti-TNF drug adalimumab into Dupuytren’s disease nodules is effective in reducing nodule hardness and nodule size.

Liposomal bupivacaine found to be no more effective than current treatments for post-operative knee pain

A new study published in JAMA, has found that a drug recently licensed in the UK has no effect on post-operative knee replacement recovery or pain, compared to the current treatment when administered at site of surgery.

Cemented hip replacement improves quality of life for patients over 60

The White 5 trial compared implants fixed with bone cement against uncemented implants for hip fractures treated with hemiarthroplasty.

FUTURE-GB looking ahead to 2022

FUTURE-GB has bounced into 2022 ahead of both predicted recruitment into Stage 2 (the Randomised Controlled Trial), and the sites open in Stage 2! Congratulations to all our sites for their hard work so far.